International
</body> Date: Thursday May 15th Time: 4:00 pm GMT (UK) | 11:00 am EST PathXL’s proprietary tumor detection software, TissueMark®, has been evolving rapidly since its launch in November 2013 and we are glad to announce a range of...
Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date: Monday,...
"We've been innovative to provide a much better pathology service for our patients. We're not going to stop there . . . our vision is that pathology really is the heart of a patient's diagnosis." – Dr. Sylvia...
Source: Dark Daily 7 May 2014 Prenatal testing, the most popular in China, is banned, affecting current projects at providers—another lesson for laboratories in how quickly things change Genetic testing has been halted in China. This...
Presenters: Dr. Bernard Fox, Endowed Chair and Chief, Laboratory of Molecular and Tumor Immunology Providence Cancer Center Dr. Carlo Bifulco, Director of Molecular Pathology and Pathology Informatics Providence Regional...
The advent of digital pathology is expected to revolutionize the healthcare industry in China and help overcome challenges in medical education, clinical practices and research. Favorable government healthcare reforms, such as initiatives...
